Primary anorectal melanoma: An update

Journal of Cancer

Volumn 3, Issue 1, 2012, Pages 449-453

  Carcoforo, P ^a   Raiji, M T ^b   Palini, G M ^a   Pedriali, M ^a   Maestroni, U ^c   Soliani, G ^a   Detroia, A ^a   Zanzi, M V ^a   Manna, A L ^a   Crompton, J G ^d   Langan, R C ^b   Stojadinovic, A ^g   Avital, I ^e,f  

^a UNIVERSITY OF FERRARA   (Italy)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY HOSPITAL OF PARMA   (Italy)

^d UCLA MEDICAL CENTER   (United States)

^e WALTER REED ARMY MEDICAL CENTER   (United States)

^f Bon Secours Cancer Institute   (United States)

^g Bon Secours National Cancer Institute ^*

Author keywords

Anorectal mucosal melanoma

Indexed keywords

TEMOZOLOMIDE;

ANORECTAL MUCOSAL MELANOMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CLINICAL FEATURE; COLOSTOMY; CUTANEOUS MELANOMA; EXCISION; HUMAN; IMMUNOHISTOCHEMISTRY; MORBIDITY; MULTIPLE CYCLE TREATMENT; PRIMARY TUMOR; RECTUM CANCER; RECTUM HEMORRHAGE;

EID: 84880571884     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.5187     Document Type: Article

References (67)

1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011; 61: 212-36. doi:10.3322/caac.20121.
2. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998; 83: 1664-78.
3. McLaughlin CC, Wu XC, Jemal A, Martin HJ, Roche LM, Chen VW. Incidence of noncutaneous melanomas in the U.S. Cancer. 2005; 103: 1000-7. doi:10.1002/cncr.20866.
4. Thibault C, Sagar P, Nivatvongs S, Ilstrup DM, Wolff BG. Anorectal melanoma-an incurable disease? Dis Colon Rectum. 1997; 40: 661-8.
5. Ross M, Pezzi C, Pezzi T, Meurer D, Hickey R, Balch C. Patterns of failure in anorectal melanoma. A guide to surgical therapy. Arch Surg. 1990; 125: 313-6.
6. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012; 62: 10-29. doi:10.3322/caac.20138.
7. Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA. Increasing burden of melanoma in the United States. J Invest Dermatol. 2009; 129: 1666-74. doi:10.1038/jid.2008.423.
8. Reed KB, Brewer JD, Lohse CM, Bringe KE, Pruitt CN, Gibson LE. Increasing incidence of melanoma among young adults: an epidemiological study in Olmsted County, Minnesota. Mayo Clin Proc. 2012; 87: 328-34. doi:10.1016/j.mayocp.2012.01.010.
9. Weyers W. The 'epidemic' of melanoma between under- and overdiagnosis. J Cutan Pathol. 2012; 39: 9-16. doi:10.1111/j.1600-0560.2011.01831.x.
10. Tomicic J, Wanebo HJ. Mucosal melanomas. Surg Clin North Am. 2003; 83: 237-52. doi:10.1016/S0039-6109(02)00100-7.
11. Bolivar JC, Harris JW, Branch W, Sherman RT. Melanoma of the anorectal region. Surg Gynecol Obstet. 1982; 154: 337-41.
12. Leonard D, Beddy D, Dozois EJ. Neoplasms of anal canal and perianal skin. Clin Colon Rectal Surg. 2011; 24: 54-63. doi:10.1055/s-0031-1272824.
13. Trodahl JN, Sprague WG. Benign and malignant melanocytic lesions of the oral mucosa. An analysis of 135 cases. Cancer. 1970; 25: 812-23.
14. Rapini RP, Golitz LE, Greer RO, Jr., Krekorian EA, Poulson T. Primary malignant melanoma of the oral cavity. A review of 177 cases. Cancer. 1985; 55: 1543-51.
15. De La Pava S, Nigogosyan G, Pickren JW, Cabrera A. Melanosis of the esophagus. Cancer. 1963; 16: 48-50.
16. Chang F, Deere H. Esophageal melanocytosis morphologic features and review of the literature. Arch Pathol Lab Med. 2006; 130: 552-7. doi:10.1043/1543-2165(2006)130[552:EMMFAR]2.0.CO;2.
17. Piris A, Rosai J. Pigmented lesions in unusual anatomic sites. Semin Diagn Pathol. 2003; 20: 249-59.
18. Walls EW. Observations on the microscopic anatomy of the human anal canal. Br J Surg. 1958; 45: 504-12.
19. Fenger C, Lyon H. Endocrine cells and melanin-containing cells in the anal canal epithelium. Histochem J. 1982; 14: 631-9.
20. Morson BC, Volkstadt H. Malignant melanoma of the anal canal. J Clin Pathol. 1963; 16: 126-32.
21. Clemmensen OJ, Fenger C. Melanocytes in the anal canal epithelium. Histopathology. 1991; 18: 237-41.
22. Werdin C, Limas C, Knodell RG. Primary malignant melanoma of the rectum. Evidence for origination from rectal mucosal melanocytes. Cancer. 1988; 61: 1364-70.
23. Nicholson AG, Cox PM, Marks CG, Cook MG. Primary malignant melanoma of the rectum. Histopathology. 1993; 22: 261-4.
24. Erickson CA. From the crest to the periphery: control of pigment cell migration and lineage segregation. Pigment Cell Res. 1993; 6: 336-47.
25. Bronner ME, Ledouarin NM. Development and evolution of the neural crest: An overview. Dev Biol. 2012; 366: 2-9. doi:10.1016/j.ydbio.2011.12.042.
26. Kawakami A, Fisher DE. Key discoveries in melanocyte development. J Invest Dermatol. 2011; 131: E2-4. doi:10.1038/skinbio.2011.2.
27. Rovasio RA, Faas L, Battiato NL. Insights into Stem Cell Factor chemotactic guidance of neural crest cells revealed by a real-time directionality-based assay. Eur J Cell Biol. 2012; 91: 375-90. doi:10.1016/j.ejcb.2011.12.007.
28. Steel KP, Davidson DR, Jackson IJ. TRP-2/DT, a new early melanoblast marker, shows that steel growth factor (c-kit ligand) is a survival factor. Development. 1992; 115: 1111-9.
29. Bondurand N, Dastot-Le Moal F, Stanchina L, Collot N, Baral V, Marlin S, et al. Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4. Am J Hum Genet. 2007; 81: 1169-85. doi:10.1086/522090.
30. Pingault V, Bondurand N, Kuhlbrodt K, Goerich DE, Prehu MO, Puliti A, et al. SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat Genet. 1998; 18: 171-3. doi:10.1038/ng0298-171.
31. Giebel LB, Spritz RA. Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism. Proc Natl Acad Sci U S A. 1991; 88: 8696-9.
32. Spritz RA. Piebaldism, Waardenburg syndrome, and related disorders of melanocyte development. Semin Cutan Med Surg. 1997; 16: 15-23.
33. Gilchrest BA, Eller MS, Geller AC, Yaar M. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med. 1999; 340: 1341-8. doi:10.1056/NEJM199904293401707.
34. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Picconi O, Boyle P, et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer. 2005; 41: 45-60. doi:10.1016/j.ejca.2004.10.016.
35. Nelemans PJ, Groenendal H, Kiemeney LA, Rampen FH, Ruiter DJ, Verbeek AL. Effect of intermittent exposure to sunlight on melanoma risk among indoor workers and sun-sensitive individuals. Environ Health Perspect. 1993; 101: 252-5.
36. Jhappan C, Noonan FP, Merlino G. Ultraviolet radiation and cutaneous malignant melanoma. Oncogene. 2003; 22: 3099-112. doi:10.1038/sj.onc.1206450.
37. Pfeifer GP, You YH, Besaratinia A. Mutations induced by ultraviolet light. Mutat Res. 2005; 571: 19-31. doi:10.1016/j.mrfmmm.2004.06.057.
38. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature. 2002; 417: 949-54. doi:10.1038/nature00766.
39. Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, et al. High frequency of BRAF mutations in nevi. Nat Genet. 2003; 33: 19-20. doi:10.1038/ng1054.
40. Grossmann AH, Grossmann KF, Wallander ML. Molecular testing in malignant melanoma. Diagn Cytopathol. 2012; 40: 503-10. doi:10.1002/dc.22810.
41. Thomas NE, Berwick M, Cordeiro-Stone M. Could BRAF mutations in melanocytic lesions arise from DNA damage induced by ultraviolet radiation? J Invest Dermatol. 2006; 126: 1693-6. doi:10.1038/sj.jid.5700458.
42. Edwards RH, Ward MR, Wu H, Medina CA, Brose MS, Volpe P, et al. Absence of BRAF mutations in UV-protected mucosal melanomas. J Med Genet. 2004; 41: 270-2.
43. Helmke BM, Mollenhauer J, Herold-Mende C, Benner A, Thome M, Gassler N, et al. BRAF mutations distinguish anorectal from cutaneous melanoma at the molecular level. Gastroenterology. 2004; 127: 1815-20.
44. Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005; 353: 2135-47. doi:10.1056/NEJMoa050092.
45. Wong CW, Fan YS, Chan TL, Chan AS, Ho LC, Ma TK, et al. BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs. J Clin Pathol. 2005; 58: 640-4. doi:10.1136/jcp.2004.022509.
46. Curtin JA, Busam K, Pinkel D, Bastian BC. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol. 2006; 24: 4340-6. doi:10.1200/JCO.2006.06.2984.
47. Beadling C, Jacobson-Dunlop E, Hodi FS, Le C, Warrick A, Patterson J, et al. KIT gene mutations and copy number in melanoma subtypes. Clin Cancer Res. 2008; 14: 6821-8. doi:10.1158/1078-0432.CCR-08-0575.
48. Giraud G, Ramqvist T, Ragnarsson-Olding B, Dalianis T. DNA from BK virus and JC virus and from KI, WU, and MC polyomaviruses as well as from simian virus 40 is not detected in non-UV-light-associated primary malignant melanomas of mucous membranes. J Clin Microbiol. 2008; 46: 3595-8. doi:10.1128/JCM.01635-08.
49. Axell T, Hedin CA. Epidemiologic study of excessive oral melanin pigmentation with special reference to the influence of tobacco habits. Scand J Dent Res. 1982; 90: 434-42.
50. Quan SH, Deddish MR. Noncutaneous melanoma. Malignant melanoma of the anorectum. CA Cancer J Clin. 1966; 16: 111-4.
51. Pack GT, Oropeza R. A comparative study of melanoma and epidermoid carcinoma of the anal canal: A review of 20 melanomas and 29 epidermoid carcinomas (1930 to 1965). Dis Colon Rectum. 1967; 10: 161-76.
52. Chiu YS, Unni KK, Beart RW, Jr. Malignant melanoma of the anorectum. Dis Colon Rectum. 1980; 23: 122-4.
53. Slingluff CL, Jr., Vollmer RT, Seigler HF. Anorectal melanoma: clinical characteristics and results of surgical management in twenty-four patients. Surgery. 1990; 107: 1-9.
54. Brady MS, Kavolius JP, Quan SH. Anorectal melanoma. A 64-year experience at Memorial Sloan-Kettering Cancer Center. Dis Colon Rectum. 1995; 38: 146-51.
55. Stoidis CN, Spyropoulos BG, Misiakos EP, Fountzilas CK, Paraskeva PP, Fotiadis CI. Diffuse anorectal melanoma; review of the current diagnostic and treatment aspects based on a case report. World J Surg Oncol. 2009; 7: 64. doi:10.1186/1477-7819-7-64.
56. Wanebo HJ, Woodruff JM, Farr GH, Quan SH. Anorectal melanoma. Cancer. 1981; 47: 1891-900.
57. Iddings DM, Fleisig AJ, Chen SL, Faries MB, Morton DL. Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment: is more extensive surgical resection beneficial in all patients? Ann Surg Oncol. 2010; 17: 40-4. doi:10.1245/s10434-009-0705-0.
58. Nilsson PJ, Ragnarsson-Olding BK. Importance of clear resection margins in anorectal malignant melanoma. Br J Surg. 2010; 97: 98-103. doi:10.1002/bjs.6784.
59. Zhou HT, Zhou ZX, Zhang HZ, Bi JJ, Zhao P. Wide local excision could be considered as the initial treatment of primary anorectal malignant melanoma. Chin Med J (Engl). 2010; 123: 585-8.
60. Moozar KL, Wong CS, Couture J. Anorectal malignant melanoma: treatment with surgery or radiation therapy, or both. Can J Surg. 2003; 46: 345-9.
61. Che X, Zhao DB, Wu YK, Wang CF, Cai JQ, Shao YF, et al. Anorectal malignant melanomas: retrospective experience with surgical management. World J Gastroenterol. 2011; 17: 534-9. doi:10.3748/wjg.v17.i4.534.
62. Kelly P, Zagars GK, Cormier JN, Ross MI, Guadagnolo BA. Sphincter-sparing local excision and hypofractionated radiation therapy for anorectal melanoma: A 20-Year Experience. Cancer. 2011. doi:10.1002/cncr.26088.
63. Damin DC, Rosito MA, Spiro BL. Long-term survival data on sentinel lymph node biopsy in anorectal melanoma. Tech Coloproctol. 2010; 14: 367-8. doi:10.1007/s10151-010-0643-7.
64. Tien HY, McMasters KM, Edwards MJ, Chao C. Sentinel lymph node metastasis in anal melanoma: a case report. Int J Gastrointest Cancer. 2002; 32: 53-6. doi:10.1385/IJGC:32:1:53.
65. Olsha O, Mintz A, Gimon Z, Gold Deutch R, Rabin I, Halevy A, et al. Anal melanoma in the era of sentinel lymph node mapping: a diagnostic and therapeutic challenge. Tech Coloproctol. 2005; 9: 60-2. doi:10.1007/s10151-005-0196-3.
66. Sanli Y, Turkmen C, Kurul S, Tas F, Mudun A, Cantez S. Sentinel lymph node biopsy for the staging of anal melanoma: report of two cases. Ann Nucl Med. 2006; 20: 629-31.
67. Mariolis-Sapsakos T, Malamitsi J, Yakoumakis E, Orfanos F. Is sentinel node mapping useful in anorectal melanoma? Hell J Nucl Med. 2008; 11: 39-42.